Role of IL-18 in second-hand smoke-induced emphysema.

Chronic second-hand smoke (SHS) exposure comprises the main risk factor for nonsmokers to develop chronic obstructive pulmonary disease (COPD). However, the mechanisms behind the chronic inflammation and lung destruction remain incompletely understood. In this study, we show that chronic exposure of Sprague-Dawley rats to SHS results in a significant increase of proinflammatory cytokine IL-18 and chemokine (C-C motif) ligand 5 in the bronchoalveolar lavage fluid (BALF) and a significant decrease of vascular endothelial growth factor (VEGF) in the lung tissue. SHS exposure resulted in progressive alveolar airspace enlargement, cell death, pulmonary vessel loss, vessel muscularization, collagen deposition, and right ventricular hypertrophy. Alveolar macrophages displayed a foamy phenotype and a decreased expression of the natural inhibitor of IL-18, namely, IL-18 binding protein (IL-18BP). Moreover, IL-18 down-regulated the expression of VEGF receptor-1 and VEGFR receptor-2, and induced apoptosis in pulmonary microvascular endothelial cells in vitro. We also observed a trend toward increased concentrations of IL-18 in the BALF of patients with COPD. Our findings suggest that IL-18-mediated endothelial cell death may contribute to vascular destruction and disappearance in SHS-induced COPD. Moreover, IL-18 and IL-18BP are potential new targets for therapeutics.

[1]  Toshinori Yoshida,et al.  Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. , 2007, Physiological reviews.

[2]  Z. Daniil,et al.  The role of leptin in the respiratory system: an overview , 2010, Respiratory research.

[3]  I. Adcock,et al.  Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction , 2008, European Respiratory Journal.

[4]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[5]  K. Meldrum,et al.  IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction , 2009, Proceedings of the National Academy of Sciences.

[6]  R. Sharrar,et al.  Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.

[7]  G. Senaldi,et al.  Role of IL-18 in Acute Lung Inflammation1 , 2001, The Journal of Immunology.

[8]  E. Piitulainen,et al.  Environmental correlates of impaired lung function in non-smokers with severe α1-antitrypsin deficiency (PiZZ) , 1998, Thorax.

[9]  C. D. Dela Cruz,et al.  Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. , 2008, The Journal of clinical investigation.

[10]  C. Dinarello,et al.  Antiviral and immunoregulatory activities of IFN-γ depend on constitutively expressed IL-1α , 2007, Proceedings of the National Academy of Sciences.

[11]  M. Morris,et al.  Cigarette smoke exposure reprograms the hypothalamic neuropeptide Y axis to promote weight loss. , 2006, American journal of respiratory and critical care medicine.

[12]  Matthias Ochs,et al.  Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. , 2010, Journal of applied physiology.

[13]  T. Shim,et al.  Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs. , 2005, American journal of respiratory and critical care medicine.

[14]  I. Adcock,et al.  Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD , 2009, Thorax.

[15]  Indoor air quality at nine large-hub airports with and without designated smoking areas--United States, October-November 2012. , 2012, MMWR. Morbidity and mortality weekly report.

[16]  D. Sandler,et al.  Deaths from all causes in non-smokers who lived with smokers. , 1989, American journal of public health.

[17]  J. Mortensen,et al.  Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  C. Dinarello,et al.  Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.

[19]  M. Lebowitz,et al.  Respiratory symptoms and pulmonary function in an elderly nonsmoking population. , 1999, Chest.

[20]  M. Cosio,et al.  Alpha1-antitrypsin determines the pattern of emphysema and function in tobacco smoke-exposed mice: parallels with human disease. , 2002, American journal of respiratory and critical care medicine.

[21]  D. Postma,et al.  Airway inflammation contributes to health status in COPD: a cross-sectional study , 2006, Respiratory research.

[22]  T. Hirayama.  Non-smoking wives of heavy smokers have a higher risk of lung cancer: a study from Japan. , 1981, British medical journal.

[23]  P. Hirth,et al.  Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.

[24]  H. Carp,et al.  Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants. , 1978, The American review of respiratory disease.

[25]  G. Fantuzzi,et al.  Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. , 1999, Immunity.

[26]  M. Cuttica,et al.  Pulmonary hypertension in advanced chronic obstructive pulmonary disease , 2012, Current opinion in pulmonary medicine.

[27]  B. Ma,et al.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism. , 2011, American journal of respiratory and critical care medicine.

[28]  C. Dinarello,et al.  Increased Cytokine Production in Interleukin-18 Receptor α-deficient Cells Is Associated with Dysregulation of Suppressors of Cytokine Signaling* , 2009, The Journal of Biological Chemistry.

[29]  Alistair Woodward,et al.  Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries , 2011, The Lancet.

[30]  H. Aizawa,et al.  Interleukin-18 production and pulmonary function in COPD , 2008, European Respiratory Journal.

[31]  N. Voelkel,et al.  COPD/emphysema: The vascular story , 2011, Pulmonary circulation.

[32]  Bo Hye Kim,et al.  IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13. , 2012, American journal of respiratory and critical care medicine.

[33]  C. Dinarello,et al.  Antiviral and immunoregulatory activities of IFN-gamma depend on constitutively expressed IL-1alpha. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Fabbri,et al.  Increased activation of p38 MAPK in COPD , 2008, European Respiratory Journal.

[35]  C. Roussos,et al.  IL-18 in induced sputum and airway hyperresponsiveness in mild asthmatics: effect of smoking. , 2009, Respiratory medicine.

[36]  E. Weibel,et al.  American Thoracic Society Documents An Official Research Policy Statement of the American Thoracic Society/European Respiratory Society: Standards for Quantitative Assessment of Lung Structure , 2010 .

[37]  C. Drevon,et al.  Cigarette smoking may reduce plasma leptin concentration via catecholamines. , 2005, Prostaglandins, leukotrienes, and essential fatty acids.

[38]  James L. Repace,et al.  Fine particle air pollution and secondhand smoke exposures and risks inside 66 US casinos. , 2011, Environmental research.

[39]  R. Stockley,et al.  Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence , 2010, Thorax.

[40]  D. Trichopoulos,et al.  PASSIVE SMOKING AND CHRONIC OBSTRUCTIVE LUNG DISEASE , 1987, The Lancet.

[41]  R. Homer,et al.  IL-18 Is Induced and IL-18 Receptor α Plays a Critical Role in the Pathogenesis of Cigarette Smoke-Induced Pulmonary Emphysema and Inflammation1 , 2007, The Journal of Immunology.

[42]  Russell P Bowler,et al.  Cigarette smoke impairs clearance of apoptotic cells through oxidant-dependent activation of RhoA. , 2009, American journal of respiratory and critical care medicine.

[43]  M. Şahin,et al.  Lower leptin levels in young non-obese male smokers than non-smokers , 2009, Upsala Journal of Medical Sciences.

[44]  W. Mitzner,et al.  Anisotropic Nature of Mouse Lung Parenchyma , 2008, Annals of Biomedical Engineering.

[45]  S. Biswal,et al.  Rtp801, a suppressor of mTOR signaling, is an essential mediator of cigarette smoke – induced pulmonary injury and emphysema , 2010, Nature Medicine.

[46]  R. Naeije,et al.  Pulmonary hypertension in COPD , 2008, European Respiratory Journal.

[47]  B. Pedersen,et al.  Elevated Levels of IL-18 in Plasma and Skeletal Muscle in Chronic Obstructive Pulmonary Disease , 2007, Lung.

[48]  Laimute Taraseviciene-Stewart,et al.  Molecular pathogenesis of emphysema. , 2008, The Journal of clinical investigation.

[49]  M Eisenstein,et al.  Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Lebowitz,et al.  Passive smoking and chronic respiratory disease symptoms in non-smoking adults. , 1993, International journal of epidemiology.

[51]  C. Dinarello.  Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. , 2006, The American journal of clinical nutrition.

[52]  V. Kim,et al.  Pathogenesis of inflammation and repair in advanced COPD. , 2010, Seminars in respiratory and critical care medicine.

[53]  H. Young,et al.  Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. , 2007, American journal of respiratory and critical care medicine.

[54]  N. Voelkel,et al.  An animal model of autoimmune emphysema. , 2005, American journal of respiratory and critical care medicine.

[55]  Edwin K Silverman,et al.  An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[56]  A. Churg,et al.  Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment , 2005, Thorax.

[57]  T. V. van Kuppevelt,et al.  Morphological Quantification of Emphysema in Small Human Lung Specimens: Comparison of Methods and Relation with Clinical Data , 2003, Modern Pathology.

[58]  J. Dankert,et al.  Letter: Cross-reaction of human serum-proteins with HBsAg. , 1974, Lancet.

[59]  H. Okamura,et al.  Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells1 , 2001, The Journal of Immunology.

[60]  Carla M. T. Bauer,et al.  Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages. , 2008, American journal of respiratory cell and molecular biology.

[61]  Dirk E. Smith,et al.  The IL-1 family: regulators of immunity , 2010, Nature Reviews Immunology.